Table 3 Unadjusted and adjusted competing-risks regression analyses of covariates and 90-day readmission among septic patients
Unadjusted subhazard ratio | Adjusted subhazard ratio (full model)a (95% CI) | Adjusted subhazard ratio (final model) (95% CI) | |
|---|---|---|---|
Ageb | 1.00 (0.99–1.01) | 0.99 (0.98–1.00) | – |
Female gender | 1.02 (0.79–1.32) | 1.06 (0.81–1.38) | – |
COPD | 1.24 (0.93–1.66) | 1.16 (0.88–1.55) | – |
Diabetes | 1.12 (0.84–1.51) | 1.09 (0.77–1.52) | – |
Kidney disease | 1.27 (0.83–1.94) | 1.13 (0.74–1.70) | – |
C-reactive proteinb | 0.998 (0.997–1.000) | 1.00 (1.00–1.00) | – |
Glucoseb | 0.99 (0.95–1.02) | 0.98 (0.94–1.02) | – |
Anticoagulant treatment | 1.31 (1.01–1.68) | 1.21 (0.91–1.61) | – |
Vasopressor treatment | 0.22 (0.03–1.72) | 0.19 (0.02–1.58) | – |
Opioid treatment | 1.43 (1.05–1.94) | 1.22 (0.90–1.67) | – |
Malignant disease | 1.70 (1.24–2.34) | 1.68 (1.20–2.33) | 1.61 (1.16–2.23) |
Previous admitted with sepsis | 1.51 (1.17–1.97) | 1.28 (0.97–1.67) | 1.41 (1.08–1.84) |
Treatment with diuretics | 1.53 (1.18–1.98) | 1.48 (1.12–1.95) | 1.51 (1.17–1.94) |